Cerecor Stock Forecast, Price & News

Cerecor (NASDAQ:CERC) Frequently Asked Questions

Is Cerecor a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cerecor in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Cerecor stock.
View analyst ratings for Cerecor or view top-rated stocks.

How were Cerecor's earnings last quarter?

Cerecor Inc. (NASDAQ:CERC) announced its quarterly earnings data on Sunday, August, 1st. The company reported ($0.18) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.17) by $0.01. The firm earned $3.36 million during the quarter. Cerecor had a negative trailing twelve-month return on equity of 261.82% and a negative net margin of 1,194.82%.
View Cerecor's earnings history.

What price target have analysts set for CERC?

4 analysts have issued 1 year price targets for Cerecor's shares. Their forecasts range from $4.00 to $9.00. On average, they expect Cerecor's stock price to reach $6.75 in the next year. This suggests a possible upside of 223.0% from the stock's current price.
View analysts' price targets for Cerecor or view top-rated stocks among Wall Street analysts.

Who are Cerecor's key executives?

Cerecor's management team includes the following people:

• Michael F. Cola, Chairman & Chief Executive Officer
• Schond L. Greenway, Chief Financial Officer & Treasurer
• H. Jeffrey Wilkins, Chief Medical Officer
• Garry Arthur Neil, Chief Scientific Officer (LinkedIn Profile)
• Younok Dumortier Shin, Chief Technology Officer

Who are some of Cerecor's key competitors?

Some companies that are related to Cerecor include Kiniksa Pharmaceuticals (KNSA), Precigen (PGEN), CytoDyn (CYDY), Imago BioSciences (IMGO), Radius Health (RDUS), Aclaris Therapeutics (ACRS), POINT Biopharma Global (PNT), Northwest Biotherapeutics (NWBO), Dyne Therapeutics (DYN), Praxis Precision Medicines (PRAX), Y-mAbs Therapeutics (YMAB), Akero Therapeutics (AKRO), Janux Therapeutics (JANX), Catalyst Pharmaceuticals (CPRX) and VBI Vaccines (VBIV).
View all of CERC's competitors.

What other stocks do shareholders of Cerecor own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cerecor investors own include ADMA Biologics (ADMA), Matinas BioPharma (MTNB), Bionano Genomics (BNGO), Gran Tierra Energy (GTE), KushCo (KSHB), Novan (NOVN), Zosano Pharma (ZSAN), Aeterna Zentaris (AEZS), OrganiGram (OGI) and Pennsylvania Real Estate Investment Trust (PEI).

What is Cerecor's stock symbol?

Cerecor trades on the NASDAQ under the ticker symbol "CERC."

Who are Cerecor's major shareholders?

Cerecor's stock is owned by a number of retail and institutional investors. Top institutional investors include Citadel Advisors LLC (0.00%). Company insiders that own Cerecor stock include Armistice Capital Master Fund, Armistice Capital, Llc, Cerecor Inc, Christopher Ryan Sullivan, Garry Arthur Neil, James Archie Harrell Jr, Joseph M Miller and Michael F Cola.
View institutional ownership trends for Cerecor.

Which major investors are selling Cerecor stock?

CERC stock was sold by a variety of institutional investors in the last quarter, including Citadel Advisors LLC.
View insider buying and selling activity for Cerecor or view top insider-selling stocks.

What is Cerecor's stock price today?

One share of CERC stock can currently be purchased for approximately $2.09.

How much money does Cerecor make?

Cerecor has a market capitalization of $200.66 million and generates $6.70 million in revenue each year. The company earns $-63.50 million in net income (profit) each year or ($0.57) on an earnings per share basis.

How many employees does Cerecor have?

Cerecor employs 31 workers across the globe.

What is Cerecor's official website?

The official website for Cerecor is www.cerecor.com.

Where are Cerecor's headquarters?

Cerecor is headquartered at 540 Gaither Road Suite 400, Rockville MD, 20850.

How can I contact Cerecor?

Cerecor's mailing address is 540 Gaither Road Suite 400, Rockville MD, 20850. The company can be reached via phone at (410) 522-8707 or via email at [email protected].